AU5937590A - A process for the preparation of drug particles - Google Patents
A process for the preparation of drug particlesInfo
- Publication number
- AU5937590A AU5937590A AU59375/90A AU5937590A AU5937590A AU 5937590 A AU5937590 A AU 5937590A AU 59375/90 A AU59375/90 A AU 59375/90A AU 5937590 A AU5937590 A AU 5937590A AU 5937590 A AU5937590 A AU 5937590A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- drug particles
- drug
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8902257 | 1989-06-21 | ||
SE8902257A SE464743B (en) | 1989-06-21 | 1989-06-21 | PROCEDURE FOR PREPARATION OF MEDICINAL PARTICLES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5937590A true AU5937590A (en) | 1991-01-08 |
Family
ID=20376358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU59375/90A Abandoned AU5937590A (en) | 1989-06-21 | 1990-06-15 | A process for the preparation of drug particles |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5937590A (en) |
SE (1) | SE464743B (en) |
WO (1) | WO1990015593A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675432B2 (en) * | 1992-07-01 | 1997-02-06 | Elan Pharma International Limited | Surface modified anticancer nanoparticles |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
DK0644755T3 (en) * | 1992-06-10 | 1997-09-22 | Nanosystems Llc | Surface Modified NSAID Nanoparticles |
US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
US5352459A (en) * | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
DE4308121A1 (en) * | 1993-03-15 | 1994-09-22 | Rhone Poulenc Rorer Gmbh | Aqueous liposome system and method for producing such a liposome system |
EP0755222A4 (en) * | 1994-04-11 | 2000-03-08 | Mallinckrodt Medical Inc | Microfluidization of calcium/oxyanion-containing particles |
FR2721510B1 (en) * | 1994-06-22 | 1996-07-26 | Rhone Poulenc Rorer Sa | Nanoparticles filterable under sterile conditions. |
SE9403846D0 (en) * | 1994-11-09 | 1994-11-09 | Univ Ohio State Res Found | Small particle formation |
GB0008411D0 (en) * | 2000-04-05 | 2000-05-24 | Vectura Ltd | Pharmaceutical preparations and their manufacture |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
CA2456806C (en) | 2001-08-08 | 2011-10-18 | Brown University Research Foundation | Methods for micronization of hydrophobic drugs |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
WO2003026611A2 (en) | 2001-09-26 | 2003-04-03 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
JP2005515224A (en) * | 2002-01-14 | 2005-05-26 | ダウ グローバル テクノロジーズ インコーポレイティド | Drug nanoparticles from template emulsion |
US20080220075A1 (en) * | 2002-03-20 | 2008-09-11 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
DE60309300T3 (en) * | 2002-03-20 | 2011-02-24 | Elan Pharma International Ltd. | NANOPARTICLE COMPOSITIONS OF ANGIOGENIC INHIBITORS |
EP1800666A1 (en) * | 2002-03-20 | 2007-06-27 | Elan Pharma International Limited | Nanoparticulate compositions of angiogenesis inhibitors |
JP4533134B2 (en) * | 2002-06-10 | 2010-09-01 | エラン ファーマ インターナショナル,リミティド | Nanoparticulate policosanol formulations and novel policosanol combinations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2348334C2 (en) * | 1973-09-26 | 1982-11-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | New form of preparation of N-4- [2- (5-chloro-2-methoxybenzamido) ethyl] -phenyl-sulfonyl-N'-cyclohexylurea |
DE2817453A1 (en) * | 1978-04-21 | 1979-10-31 | Rohner Ag | Water dispersible granulate and powder contg. insoluble components - e.g. dyes, brighteners and pigments, contain acid polymeric carrier which dissolves in aq. base |
CA1282405C (en) * | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
-
1989
- 1989-06-21 SE SE8902257A patent/SE464743B/en not_active Application Discontinuation
-
1990
- 1990-06-15 AU AU59375/90A patent/AU5937590A/en not_active Abandoned
- 1990-06-15 WO PCT/SE1990/000426 patent/WO1990015593A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675432B2 (en) * | 1992-07-01 | 1997-02-06 | Elan Pharma International Limited | Surface modified anticancer nanoparticles |
Also Published As
Publication number | Publication date |
---|---|
SE8902257L (en) | 1990-12-22 |
SE8902257D0 (en) | 1989-06-21 |
SE464743B (en) | 1991-06-10 |
WO1990015593A1 (en) | 1990-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU621898B2 (en) | Process for the preparation of a polypropylene | |
AU5937590A (en) | A process for the preparation of drug particles | |
AU5112993A (en) | Process for the preparation of drug pellets | |
AU5872290A (en) | Process for the preparation of cycloolefin polymers | |
AU2227188A (en) | New cephem compound and a process for preparation thereof | |
ZA906536B (en) | Process for the preparation of a polyefin | |
GB2225322B (en) | A process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide | |
AU626685B2 (en) | Process for the manufacture of a poly-l-olefin | |
AU4935390A (en) | A novel substituted-acetamide compound and a process for the preparation thereof | |
EP0427965A3 (en) | Process for the preparation of cyclohexanol derivatives | |
AU6266090A (en) | Process for the preparation of catalysts | |
AU603445B2 (en) | Process for preparing a pharmaceutical composition | |
AU3377989A (en) | Process for the preparation of N-phosphonomethylglycine | |
AU4876490A (en) | A process for the preparation of triazinic polymers | |
HU902047D0 (en) | Process for the preparation of pharmaceutical product | |
EG18306A (en) | A process for the preparation of pharmaceutical compounds | |
AU5371590A (en) | A process for the preparation of etoposides | |
AU5067590A (en) | New bronchospasmolytic compounds and process for their preparation | |
AU3271089A (en) | Process for the preparation of alkanediols | |
AU5390690A (en) | A process for the preparation of penem compounds | |
AU1509488A (en) | Benzenesulfonamide derivatives and a process for the preparation thereof | |
AU5913090A (en) | A novel process for the preparation of 2-diazo-3- trisubstituted silyloxy-3-butenoates | |
AU6255690A (en) | Opaliform porcellanite and process for the preparation thereof | |
AU3136589A (en) | Process for the preparation of alkanediols | |
AU7095691A (en) | A process for the preparation of 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid |